Lilly
Pharma

Lilly ups oral SERD battle with Inluriyo, Verzenio combo nod

Lilly’s Inluriyo-Verzenio regimen could challenge AstraZeneca’s argument for its novel first-line switch approach with an oral SERD.
Angus Liu Sep 18, 2026 3:30pm
How is API Manufacturing Changing

How is API Manufacturing Changing?

Brought to you by WuXi AppTec
European Union flags waving in front of the EU Parliament building in Brussels

Europe recommends Novo's Frehemgo and AZ's Klygefa

Sep 18, 2026 11:23am
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Holiday takes toll on prescriptions

Sep 18, 2026 11:20am
Fierce Pharma Week 2026

A virtual tour through the glitz and glam of Fierce Pharma Week

Sep 18, 2026 11:05am
Asia

US' China deal policy, WCLC, Legend CEO—Fierce Pharma Asia

Sep 18, 2026 10:20am
More News

FDA approves Ultragenyx gene therapy after prior rejection

Sep 17, 2026 4:50pm

Bayer’s Kerendia scores FDA nod for CKD in Type 1 diabetes

Sep 17, 2026 2:06pm

Roche reports positive confirmatory trial readout for Lunsumio

Sep 17, 2026 11:25am

Bavarian Nordic taps Sanofi vet to replace outgoing CEO Chaplin

Sep 17, 2026 11:16am